{"id":"W2317389943","doi":"10.1097/spc.0b013e32834903aa","title":"Recent advances in second-line treatment of castration-resistant prostate cancer","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Cabazitaxel; Docetaxel; Medicine; Taxane; Prostate cancer; Abiraterone acetate; Oncology; Androgen receptor; Androgen deprivation therapy; Internal medicine; Pharmacology; Chemotherapy; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007280915,0.000453691,0.001724407,0.0003291768,0.0000215065,0.000005549194,0.00006714828,0.0001647136,0.0005135125],"category_scores_gemma":[0.0000538175,0.000347486,0.0002013428,0.0003173736,0.0001594201,0.00007102996,0.00004616778,0.0002321306,0.000004442186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005667239,"about_ca_system_score_gemma":0.0007786507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001555512,"about_ca_topic_score_gemma":0.0002891347,"domain_scores_codex":[0.9977325,0.0001924221,0.001051517,0.0005927662,0.0001436745,0.0002870895],"domain_scores_gemma":[0.9985897,0.00009874661,0.0006461705,0.0002378924,0.0002935466,0.0001339362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002826156,0.0003436256,0.02339158,0.04615402,0.0000623378,0.00001840799,0.004417122,6.265541e-7,5.70785e-7,0.00004463757,0.00003861767,0.9252458],"study_design_scores_gemma":[0.001593404,0.0009207799,0.01110884,0.03239012,0.0002279629,0.000003943655,0.0007622998,9.730309e-7,0.000007451102,0.00002519485,0.9526874,0.0002716645],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001044602,0.9924835,0.000001740913,0.00001466632,0.001343197,0.00235704,0.002590818,0.00000903166,0.0001554133],"genre_scores_gemma":[0.0003057986,0.9959814,0.00002486175,0.000004457225,0.000152695,0.001227203,0.002224657,0.00003142358,0.00004752408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9526488,"threshold_uncertainty_score":0.9998977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2185481279270187,"score_gpt":0.4815987656151265,"score_spread":0.2630506376881078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}